Treatment of Ocular Larva Migrans with Active Intraocular Inflammation

When ocular larva migrans is accompanied by active intraocular inflammation, controlling the inflammatory process is central to management and preserving vision.

Clinical Scenario

This protocol applies to patients with ocular larva migrans in whom active intraocular inflammation is present in the eye. Managing the inflammatory response is the primary clinical priority in this setting.

Treatment Approach

The standard approach involves corticosteroid therapy — both topical and systemic — to manage intraocular inflammation. Anthelmintic therapy may be considered in combination with corticosteroid. The complete regimen, including all therapeutic options, sequencing, and patient-specific considerations, is available in the full protocol.

Treatment Goal

Reduction of intraocular inflammation in the eye.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.5415/apallergy.2014.4.3.134

Current standard treatment for ocular toxocariasis is corticosteroid administration in patients with active intraocular inflammation.

Topical and systemic corticosteroids are useful in managing intraocular inflammation and may reduce vitreous opacification and membrane formation.

View source ↗